Skip to main content
. 2015 Jan 23;22(7):1192–1202. doi: 10.1038/cdd.2014.217

Figure 1.

Figure 1

CD95 expression is upregulated in PDAC. (a) CD95 expression in matched tumour (n=36) and non-tumour samples (n=36) from pancreatic cancer patients (***P-value=9.083e−07, Wilcoxon's signed-rank test). (b) Ratio of CD95 expression in matched tumour and non-tumour samples from pancreatic cancer patients (GSE15471 data set). (c) Analysis of CD95 staining of PDAC sample-derived TMA. Tissue samples were differentially scored for intensity and abundance of CD95-positive tumour cells. Grey scale represents the number of tumour samples. Immunostaining indicates high CD95 expression in tumour tissue compared with surrounding stroma. Asterisk denotes tumour. Scale bar: 50 μm